Ocugen, Inc. SEC filings OCGN
Ocugen, Inc. has 892 filings in SEC EDGAR's recent list, going back to Aug 7, 2006. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| PRER14A | Filing | Apr 20, 2026 | — |
| EFFECT | Filing | Feb 13, 2025 | — |
| CORRESP | Letter to the SEC | Feb 11, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 6, 2025 | — |
| 8-A12G | Form 8-a12g | May 10, 2024 | — |
| EFFECT | Filing | May 1, 2024 | — |
| CORRESP | Letter to the SEC | Apr 29, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 25, 2024 | — |
| NT 10-K | Filing | Apr 1, 2024 | Dec 31, 2023 |
| UPLOAD | Letter from the SEC | Oct 12, 2023 | — |
| CORRESP | Letter to the SEC | Oct 4, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 19, 2023 | — |
| NT 10-Q | Filing | Aug 15, 2023 | Jun 30, 2023 |
| EFFECT | Filing | Apr 21, 2023 | — |
| POSASR | Filing | Feb 28, 2023 | — |
| DEFR14A | Filing | Dec 23, 2020 | — |
| D | Filing | May 7, 2020 | — |
| D | Filing | May 7, 2020 | — |
| EFFECT | Filing | May 5, 2020 | — |
| CORRESP | Letter to the SEC | May 4, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 6, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 19, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 6, 2020 | — |
| EFFECT | Filing | Nov 5, 2019 | — |
| CORRESP | Letter to the SEC | Nov 1, 2019 | — |
| CORRESP | Letter to the SEC | Oct 28, 2019 | — |
| UPLOAD | Letter from the SEC | Oct 18, 2019 | — |
| 425 | 8-k | Sep 26, 2019 | — |
| 425 | Filing | Sep 20, 2019 | — |
| 425 | Filing | Sep 12, 2019 | — |
| 425 | 8-k | Sep 12, 2019 | — |
| 425 | 8-k | Sep 11, 2019 | — |
| 425 | Filing | Sep 5, 2019 | — |
| 425 | Filing | Sep 4, 2019 | — |
| 425 | Filing | Aug 29, 2019 | — |
| 425 | Filing | Aug 28, 2019 | — |
| 425 | Filing | Aug 22, 2019 | — |
| 425 | Filing | Aug 19, 2019 | — |
| 425 | Filing | Aug 15, 2019 | — |
| EFFECT | Filing | Aug 6, 2019 | — |
| CORRESP | Letter to the SEC | Aug 2, 2019 | — |
| CORRESP | Letter to the SEC | Aug 2, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 31, 2019 | — |
| CORRESP | Letter to the SEC | Jul 23, 2019 | — |
| 425 | 8-k | Jul 19, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2019 | — |
| 425 | 8-k | Jul 3, 2019 | — |
| RW | Filing | Jun 27, 2019 | — |
| 425 | 8-k | Jun 21, 2019 | — |
| 425 | 8-k | Jun 14, 2019 | — |
| 425 | 8-k | Jun 3, 2019 | — |
| 425 | 8-k/a | May 13, 2019 | — |
| 425 | Form 8-k | May 13, 2019 | — |
| 425 | 8-k | Apr 18, 2019 | — |
| 425 | Filing | Apr 8, 2019 | — |
| 425 | 8-k | Apr 8, 2019 | — |
| CT ORDER | Filing | Mar 30, 2018 | — |
| CT ORDER | Filing | May 22, 2017 | — |
| EFFECT | Filing | Mar 30, 2017 | — |
| EFFECT | Filing | Nov 4, 2016 | — |
| CORRESP | Letter to the SEC | Nov 2, 2016 | — |
| UPLOAD | Letter from the SEC | Oct 28, 2016 | — |
| CORRESP | Letter to the SEC | Oct 27, 2016 | — |
| PRER14A | Filing | Oct 27, 2016 | — |
| UPLOAD | Letter from the SEC | Oct 25, 2016 | — |
| D | Filing | Oct 12, 2016 | — |
| CT ORDER | Filing | Sep 15, 2016 | — |
| CT ORDER | Filing | Dec 29, 2014 | — |
| EFFECT | Filing | Dec 2, 2014 | — |
| CERTNAS | Auto-generated paper document | Dec 1, 2014 | — |
| CORRESP | Letter to the SEC | Nov 28, 2014 | — |
| CORRESP | Letter to the SEC | Nov 28, 2014 | — |
| 8-A12B | Filing | Nov 18, 2014 | — |
| CORRESP | Letter to the SEC | Oct 27, 2014 | — |
| CORRESP | Letter to the SEC | Oct 24, 2014 | — |
| CORRESP | Letter to the SEC | Oct 23, 2014 | — |
| DRS/A | Filing | Oct 6, 2014 | — |
| DRS/A | Filing | Jul 11, 2014 | — |
| UPLOAD | Letter from the SEC | Jun 4, 2014 | — |
| DRS/A | Filing | May 16, 2014 | — |
| UPLOAD | Letter from the SEC | Apr 25, 2014 | — |
| DRS/A | Filing | Apr 11, 2014 | — |
| DRS/A | Filing | Mar 20, 2014 | — |
| UPLOAD | Letter from the SEC | Mar 13, 2014 | — |
| DRS | Filing | Feb 14, 2014 | — |
| D | Filing | Jan 6, 2014 | — |
| D/A | Filing | Nov 26, 2012 | — |
| D | Filing | Jul 27, 2012 | — |
| D | Filing | May 26, 2011 | — |
| REGDEX | Auto-generated paper document | Aug 5, 2008 | — |
| REGDEX | Auto-generated paper document | Aug 7, 2006 | — |
Showing 91 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- OCGN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Malvern, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1372299
- Former names
- HISTOGENICS CORP (until Sep 26, 2019)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.